Wikipedia - Citalopram

Citalopram
Systematic (IUPAC) name
(RS)-1-[3-(dimethylamino)propyl]-1-
(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
Identifiers
CAS number 59729-33-8
ATC code N06AB04 N06AB10
PubChem CID 2771
DrugBank DB00215
ChemSpider 2669
Chemical data
Formula C20H21FN2O 
Mol. mass 324.392 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability 80%
Metabolism hepatic (CYP3A4 & CYP2C19)
Half-life 35 hours
Excretion Mostly as unmetabolized citalopram, partly DCT and traces of DDCT in urine
Therapeutic considerations
Pregnancy cat. C(US)
Legal status ? Prescription only
Routes Oral
 YesY(what is this?)  (verify)

Citalopram (trade names: Celexa, Cipramil) is an antidepressant drug of the selective serotonin reuptake inhibitor (SSRI) class. Most often used to treat major depression, it is also used on occasion in the treatment of body dysmorphic disorder, anxiety, and panic disorder.

Contents

[edit] History

Citalopram (pronounced /sa?'tæl?præm/)[1] was originally created in 1989[2] by the pharmaceutical company Lundbeck. The patent expired in 2003, allowing other companies to legally produce generic versions. Lundbeck has recently released an updated formulation called escitalopram (also known as Cipralex or Lexapro),[citation needed] which is the S-enantiomer of the racemic citalopram (see b), and acquired a new patent for it. In the United States, Forest Labs manufactures and markets the drug.

[edit] Indications

[edit] Approved

Citalopram HBr tablets in 20 mg (coral, marked 508) and 40 mg (white, marked 509), and a US Penny.

Citalopram is used to treat the symptoms of major depression, social anxiety disorder, panic disorder and OCD.

Citalopram is a Pgp substrate and is actively transported by that protein from the brain. The efficacy of citalopram in people possessing a certain version of Pgp (genetic TT-allele) is likely to be diminished. This suggests that in non-responders to citalopram a switch to an antidepressant which is not a Pgp substrate, such as fluoxetine (Prozac, Fontex) or mirtazapine (Remeron)—but not to venlafaxine (Effexor), amitriptyline (Elavil) or paroxetine (Paxil), which are Pgp substrates—may be beneficial.[3]

[edit] Unapproved, off-label and investigational

Citalopram has been found to greatly reduce the symptoms of diabetic neuropathy[4] and premature ejaculation.[5] There is also evidence that citalopram may be effective in the treatment of post-stroke pathological crying.[6]

While on its own citalopram is less effective than amitriptyline in the prevention of migraines, in refractory cases combination therapy may be more effective.[7]

A 2009 multisite randomized controlled study found no benefit and some adverse effects in autistic children from citalopram, raising doubts whether SSRIs are effective for treating repetitive behavior in children with autism.[8]

Some research suggests that citalopram interacts with cannabinoid protein-couplings in the rat brain, and this is put forward as a potential cause of some of the drug's antidepressant effect.[9]

[edit] Availability

Citalopram is sold under the brand-names Celexa (U.S. and Canada, Forest Laboratories, Inc.), Cipramil (Australia, Brazil, Finland, Germany, Neherlands, Ireland, Norway, Sweden, United Kingdom, New Zealand, South Africa), Elopram (Italy)[10] Citol, Vodelax (Turkey), Citrol, Seropram, Talam (Europe and Australia), Citabax, Citaxin (Poland), Citalec (Slovakia, Czech Republic), Recital (Israel, Thrima Inc. for Unipharm Ltd.), Zetalo (India), Celapram, Ciazil (Australia, New Zealand), Zentius, Cimal (South America, by Roemmers and Recalcine), Ciprapine (Ireland), Cilift (South Africa), Citox (Mexico), Temperax (Chile, Peru, Argentina), Citopam, Akarin (Denmark, Nycomed), Cipram (Turkey, Denmark, H. Lundbeck A/S), Dalsan (Eastern Europe), Pramcit (Pakistan), and Celius (Greece), Humorup (Argentina), Oropram (Iceland, Actavis).

[edit] Dosage and administration

Citalopram is available in 10 mg, 20 mg, and 40 mg tablets, as well as 10 mg/5 mL peppermint flavor oral solution. The recommended starting dose is 20 mg/day, with a target dose of 40 mg/day. Increased efficacy has not been proven beyond 40 mg/day, but some prescribers may increase the dose to 60 mg/day or more. The recommendation is that dose increases do not exceed 20 mg/day increases per week.

Citalopram is generally considered safe and well-tolerated in the therapeutic dose range of 10 to 60 mg/day (a dose of 60 mg/day is reserved for patients who do not respond to lower doses). A doctor must always monitor a patient taking an SSRI such as citalopram. Distinct from some other agents in its class, citalopram exhibits linear pharmacokinetics and minimal drug interaction potential, making it a better choice for the elderly or comorbid patients.[11]

[edit] Side effects and drug interactions

Citalopram should not be taken with St John's wort, as the resulting drug interaction could lead to serotonin syndrome.[12] This may be caused by compounds in the plant extract reducing the efficacy of the hepatic cytochrome P450 enzymes that process citalopram.[13] It has also been suggested that such compounds, including hypericin, hyperforin and flavonoids, could have SSRI-mimetic effects on the nervous system, although this is still subject to debate.[14] One study found that Hypericum extracts had similar effects in treating moderate depression as citalopram, with fewer side effects.[15]

Citalopram can have a number of adverse effects. In clinical trials, over 10% of patients reported one or more of the following side effects: fatigue, drowsiness, dry mouth, increased sweating (hyperhidrosis), trembling, headache, dizziness, excessive yawning, sleep disturbances, insomnia, cardiac arrhythmia, bruxism, hallucinations, blood pressure changes, nausea and/or vomiting, diarrhea, heightened anorgasmia in females, impotence and ejaculatory problems in males. In rare cases (around over 1% of cases), some allergic reactions, convulsions, mood swings, anxiety and confusion have been reported. Also sedation may be present during treatment of citalopram. If this occurs it is advisable to take the dose at bedtime instead of in the morning. Petechia can occur if blood thinners are taken along with Citalopram.[citation needed]

When taken with Prilosec, the clearance of citalopram may be reduced, leading to higher blood levels of citalopram. Prilosec inhibits the CYP450 2C19 enzyme, one of the two primary enzymes responsible for the metabolism of citalopram. Dosage adjustments may be needed due to this effect.  

Citalopram and other SSRIs have been shown to cause some degree of sexual dysfunction in a majority of patients.[16]

Citalopram is contraindicated in individuals taking MAOIs. The drug is considered relatively safe in overdose, although fatal cases of dosages 840 mg to 1960 mg have been reported.[17]

SSRI discontinuation syndrome has been reported when treatment is stopped. Tapering off citalopram therapy, as opposed to abrupt discontinuation, is recommended in order to diminish the occurrence and severity of discontinuation symptoms. Some doctors may choose to switch a patient to Prozac (Fluoxetine) when discontinuing Celexa as Prozac has a much longer half-life (i.e. stays in the body longer compared to Celexa). This may avoid many of the severe withdrawal symptoms associated with Celexa discontinuation. This can be done either by administering a single 20 mg dose of Prozac or by beginning on a low dosage of Prozac and slowly tapering down. Either of these prescriptions may be written in liquid form to allow a very slow and gradual tapering down in dosage. Alternatively, a patient wishing to stop taking Celexa may visit a compounding pharmacy where his or her prescription may be re-arranged into progressively smaller dosages. The lowest dose of celexa that can normally be prescribed is 20 mg capsules; a compounding pharmacist may divide this into doses of 20, 15, 10, 5 and 2.5 mg so that a proper tapered reduction may take place.

[edit] Overdosage

Acute overdosage, usually intentional, has been observed in a number of instances but the outcome is generally favorable. Doses exceeding 600 mg often result in adverse electrocardiographic changes, while larger amounts can cause seizures. A number of overdose deaths have occurred, sometimes involving other drugs but also with citalopram as the sole agent. Citalopram and N-desmethylcitalopram may be quantitated in blood or plasma to confirm a diagnosis of poisoning in hospitalized patients or to assist in a medicolegal death investigation. Blood or plasma citalopram concentrations are usually in a range of 50-400 µg/L in persons receiving the drug therapeutically, 1000-3000 µg/L in patients who survive acute overdosage and 3-30 mg/L in those who do not survive.[18][19][20]

[edit] Stereochemistry

Citalopram has one stereocenter, to which a 4-fluorophenyl group and an N,N-dimethyl-3-aminopropyl group bind. Due to this chirality, the molecule exists in (two) enantiomeric forms (mirror images). They are termed S-(+)-citalopram and R-(–)-citalopram.

S-(+)-citalopram R-(–)-citalopram
S-(+)-citalopram R-(–)-citalopram
(S)-(+)-citalopram (R)-(–)-citalopram

Citalopram is sold as a racemic mixture, consisting of 50% (R)-(-)-citalopram and 50% (S)-(+)-citalopram. Only the (S)-(+) enantiomer has the desired antidepressant effect. Lundbeck now markets the (S)-(+) enantiomer, the generic name of which is escitalopram. Whereas citalopram is supplied as the hydrobromide, escitalopram is sold as the oxalate salt (hydrooxalate).[21] In both cases, the salt forms of the amine makes these otherwise lipophilic compounds water-soluble.

[edit] Metabolites

Citalopram metabolites desmethylcitalopram and didesmethylcitalopram are significantly less active, and their contribution to the overall action of citalopram is negligible.

[edit] References

  1. ^ "citalopram". Merriam-Webster, Incorporated. http://medical.merriam-webster.com/medical/citalopram. Retrieved 2008-10-13. 
  2. ^ Dorell K, Cohen MA, Huprikar SS, Gorman JM, Jones M (2005). "Citalopram-induced diplopia". Psychosomatics 46 (1): 91–3. doi:10.1176/appi.psy.46.1.91. PMID 15765832. 
  3. ^ Uhr M, Tontsch A, Namendorf C, Ripke S, Lucae S, Ising M, Dose T, Ebinger M, Rosenhagen M, Kohli M, Kloiber S, Salyakina D, Bettecken T, Specht M, Pütz B, Binder EB, Müller-Myhsok B, Holsboer F (2008). "Polymorphisms in the Drug Transporter Gene ABCB1 Predict Antidepressant Treatment Response in Depression". Neuron 57 (2): 203–9. doi:10.1016/j.neuron.2007.11.017. PMID 18215618. 
  4. ^ Sindrup SH, Bjerre U, Dejgaard A, Brøsen K, Aaes-Jørgensen T, Gram LF (1992). "The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy". Clin. Pharmacol. Ther. 52 (5): 547–52. PMID 1424428. 
  5. ^ Atmaca M, Kuloglu M, Tezcan E, Semercioz A (2002). "The efficacy of citalopram in the treatment of premature ejaculation (prem-e): a placebo-controlled study". Int. J. Impot. Res. 14 (6): 502–5. doi:10.1038/sj.ijir.3900918. PMID 12494286. 
  6. ^ Andersen G, Vestergaard K, Riis JO (1993). "Citalopram for post-stroke pathological crying". Lancet 342 (8875): 837–9. doi:10.1016/0140-6736(93)92696-Q. PMID 8104273. 
  7. ^ Rampello L, Alvano A, Chiechio S, et al. (2004). "Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache". Neuropsychobiology 50 (4): 322–8. doi:10.1159/000080960. PMID 15539864. 
  8. ^ King BH, Hollander E, Sikich L et al. (2009). "Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism". Arch Gen Psychiatry 66 (6): 583–90. doi:10.1001/archgenpsychiatry.2009.30. PMID 19487623. Lay summary – Los Angeles Times (2009-06-02). 
  9. ^ Effects of chronic treatment with citalopram on cannabinoid and opioid receptor-mediated G-protein coupling in discrete rat brain regions. Shirley A. Hesketh, Adrian K. Brennan, David S. Jessop and David P. Finn. Springer Berlin / Heidelberg. Volume 198, Number 1 / May, 2008. ISSN: 0033-3158 (Print) 1432-2072 (Online) http://www.springerlink.com/content/2127100x043n3674/
  10. ^ http://www.drugs.com/international/elopram.html
  11. ^ Keller MB (2000). "Citalopram therapy for depression: a review of 10 years of European experience and data from U.S. clinical trials". The Journal of clinical psychiatry 61 (12): 896–908. PMID 11206593. http://www.biopsychiatry.com/citalopram.html. 
  12. ^ Karch, Amy (2006). 2006 Lippincott's Nursing Drug Guide. Philadephia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo: Lippincott Williams & Wilkins. ISBN 1-58255-436-6. 
  13. ^ http://www.medsafe.govt.nz/Profs/PUarticles/sjw.htm accessed Feb 27 2009
  14. ^ http://www.umm.edu/altmed/articles/st-johns-000276.htm accessed Feb 27 2009
  15. ^ M. Gastpar, et al. (2006). "Comparative Efficacy and Safety of a Once-Daily Dosage of Hypericum Extract STW3-VI and Citalopram in Patients with Moderate Depression: A Double-Blind, Randomised, Multicentre, Placebo-Controlled Study". Pharmacopsychiatry 39 (2): 66–75. doi:10.1055/s-2006-931544. PMID 16555167. http://www.thieme-connect.com/ejournals/abstract/pharmaco/doi/10.1055/s-2006-931544. Retrieved Feb 27 2009. 
  16. ^ Clayton A, Keller A, McGarvey EL (2006). "Burden of phase-specific sexual dysfunction with SSRIs". Journal of affective disorders 91 (1): 27–32. doi:10.1016/j.jad.2005.12.007. PMID 16430968. 
  17. ^ "Citalopram Hydrobromide Brand name: Celexa Drug monograph; Symptoms and Treatment of Overdosage". Internet Mental Health. August 1999. http://www.mentalhealth.com/drug/p30-c04.html#Head_12. Retrieved 2007-07-25. ]
  18. ^ Personne M, Sjöberg G, Persson H. Citalopram overdose--review of cases treated in Swedish hospitals. J. Tox. Clin. Tox. 35: 237-240, 1997.
  19. ^ Luchini D, Morabito G, Centini F. Case report of a fatal intoxication by citalopram. Am. J. For. Med. Pathol. 26: 352-354, 2005.
  20. ^ R. Baselt, Disposition of Toxic Drugs and Chemicals in Man, 8th edition, Biomedical Publications, Foster City, CA, 2008, pp. 319-322.
  21. ^ Celexa.com

[edit] External links


This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Citalopram".

Need A Celexa Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Want to contact a Washington, DC Celexa attorney? ...Get a free case evaluation from one of our Washington, DC Celexa attorneys now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Celexa Case - Submit Your Information Below

Do you need legal assistance with your Celexa case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Celexa Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.